Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease

Neuron
Christoph HockRoger M Nitsch

Abstract

To test whether antibodies against beta-amyloid are effective in slowing progression of Alzheimer's disease, we assessed cognitive functions in 30 patients who received a prime and a booster immunization of aggregated Abeta(42) over a 1 year period in a placebo-controlled, randomized trial. Twenty patients generated antibodies against beta-amyloid, as determined by tissue amyloid plaque immunoreactivity assay. Patients who generated such antibodies showed significantly slower rates of decline of cognitive functions and activities of daily living, as indicated by the Mini Mental State Examination, the Disability Assessment for Dementia, and the Visual Paired Associates Test of delayed recall from the Wechsler Memory Scale, as compared to patients without such antibodies. These beneficial clinical effects were also present in two of three patients who had experienced transient episodes of immunization-related aseptic meningoencephalitis. Our results establish that antibodies against beta-amyloid plaques can slow cognitive decline in patients with Alzheimer's disease.

Associated Clinical Trials

Jun 16, 2015·Tzvi Dwolatzky

References

Jun 13, 2000·Alzheimer Disease and Associated Disorders·E Giacobini
Jul 18, 2002·Trends in Pharmacological Sciences·Diana Ines Dominguez, Bart De Strooper
Dec 20, 2002·Nature·Howard L Weiner, Dennis J Selkoe

❮ Previous
Next ❯

Citations

Nov 9, 2005·Archives of General Psychiatry·Roger N Rosenberg
May 17, 2006·Aging Clinical and Experimental Research·Angelo BianchettiMarco Trabucchi
Dec 6, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Andreas H JacobsPedro Lowenstein
Jul 16, 2010·Acta Neuropathologica·Delphine BocheJames A R Nicoll
Dec 17, 2009·Brain Structure & Function·Thomas Wisniewski, Allal Boutajangout
Oct 14, 2006·Journal of Neural Transmission·K A Jellinger
May 6, 2009·Journal of Neural Transmission·Andrea MarcelloThomas A Bayer
Feb 24, 2010·Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs·Kazunori KawaguchiSatoshi Sugiyama
Dec 6, 2012·Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs·Kazunori KawaguchiNobuya Kitaguchi
May 25, 2005·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Melvin K SimmonsMichael C Montalto
Jul 9, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Rachel A KarlnoskiDave Morgan
Oct 24, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Dave MorganPaula Bickford
Dec 5, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Sriram VennetiJulia Kofler
Jan 13, 2010·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Qing-you LiDave Morgan
Aug 25, 2006·Current Neurology and Neuroscience Reports·David S Knopman
Aug 25, 2006·Current Neurology and Neuroscience Reports·Eric R SiemersPatrick C May
Jun 11, 2008·Neuromolecular Medicine·Esther S OhStina M Fangmark Tucker
Aug 15, 2013·Drugs & Aging·Camryn Berk, Marwan N Sabbagh
Mar 15, 2005·Biochemical Pharmacology·Lary C WalkerSam Gandy
Mar 24, 2004·Mechanisms of Ageing and Development·Sam GandyEvan T Keller
Mar 10, 2004·Neurobiology of Disease·E Hellström-LindahlA Nordberg
Aug 18, 2004·Neurobiology of Aging·Timothy J SeabrookCynthia A Lemere
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Randall J Bateman, William E Klunk
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Roger M Nitsch, Christoph Hock
Nov 26, 2010·Immunology and Cell Biology·Francesca MantileAntonella Prisco
Oct 30, 2008·Molecular Psychiatry·J K FosterR N Martins
Jun 17, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Deborah A RyanWilliam J Bowers
Aug 6, 2004·Nature·Mark P Mattson
Aug 26, 2006·Nature Clinical Practice. Nephrology·Julian D Gillmore, Philip N Hawkins
Sep 23, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alena V SavonenkoDon L Price
Apr 28, 2006·Nature Reviews. Immunology·Howard L Weiner, Dan Frenkel
Jan 25, 2007·Nature Reviews. Molecular Cell Biology·Christian Haass, Dennis J Selkoe
Aug 24, 2004·Nature Reviews. Neuroscience·Martin Citron
Feb 9, 2010·Nature Reviews. Neurology·Cynthia A Lemere, Eliezer Masliah
Jul 2, 2004·The New England Journal of Medicine·Jeffrey L Cummings
Jan 29, 2010·The New England Journal of Medicine·Henry W Querfurth, Frank M LaFerla
Feb 28, 2009·Proceedings of the National Academy of Sciences of the United States of America·Deepak R ThakkerLisa L Shafer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.